What is the recommended dose of ondansetron (generic name) for an adult or adolescent patient with no significant contraindications or allergies, receiving cisplatin 60 mg/m² for cancer treatment?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 10, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Ondansetron Dosing for Cisplatin 60 mg/m²

For cisplatin 60 mg/m², administer ondansetron 8 mg IV 30 minutes before chemotherapy, combined with dexamethasone 10-20 mg IV, followed by ondansetron 8 mg orally every 8 hours for up to 7 doses after chemotherapy. 1, 2

Initial Prophylactic Dosing

  • Administer ondansetron 8 mg IV over 15 minutes, given 30 minutes before cisplatin infusion starts 3, 1, 4
  • Alternatively, a single oral dose of 24 mg can be given 30 minutes before chemotherapy, though IV administration is preferred for highly emetogenic regimens 5, 6
  • The 32 mg IV single dose is no longer recommended due to QT prolongation concerns without additional efficacy benefit 4, 5

Mandatory Combination Therapy

  • Always combine ondansetron with dexamethasone 10-20 mg IV on day 1 for enhanced antiemetic control 7, 1, 8
  • This combination is significantly more effective than ondansetron monotherapy, achieving complete control of nausea in 92% versus 41% with ondansetron alone 8
  • Cisplatin 60 mg/m² falls into the highly emetogenic category, making corticosteroid combination essential 2, 9

Post-Chemotherapy Continuation Dosing

  • Continue ondansetron 8 mg orally every 8 hours for 7 doses after cisplatin administration to prevent delayed emesis 7, 1
  • Combine with dexamethasone 4-8 mg orally twice daily for 2-3 days after chemotherapy for delayed phase control 1
  • Delayed emesis with cisplatin 60 mg/m² is dose-dependent and requires extended prophylaxis beyond the acute 24-hour period 10

Rescue Therapy for Breakthrough Symptoms

  • If nausea/vomiting occurs despite prophylaxis, administer ondansetron 8 mg IV bolus followed by 1 mg/hour continuous infusion for hospitalized patients 7, 1
  • Add a dopamine antagonist from a different class (metoclopramide 20-30 mg orally or prochlorperazine 10 mg orally every 6 hours) for refractory cases 3, 1
  • Consider adding lorazepam 1 mg orally every 1 hour as needed for anticipatory nausea or anxiety-related symptoms 7, 1

Critical Considerations and Common Pitfalls

  • Ondansetron monotherapy is insufficient for cisplatin 60 mg/m²—failure to add dexamethasone results in significantly worse outcomes 2, 8
  • Research demonstrates that with cisplatin 60 mg/m², ondansetron alone achieves only 20% complete response in the acute phase, versus 70% when combined with dexamethasone 2
  • The oral route is acceptable for routine prophylaxis, but IV administration is preferred when active nausea/vomiting is present 1, 4
  • Maximum single IV dose should not exceed 16 mg due to cardiac safety concerns 4
  • Complete response rates for ondansetron with cisplatin ≥60 mg/m² range from 60-66% in the acute phase, with delayed emesis being more difficult to control 9, 10

References

Guideline

Ondansetron Dosage and Frequency for Chemotherapy-Induced Nausea and Vomiting

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Ondansetron Dosing for Nausea Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Ondansetron Dosing for Nausea and Vomiting

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Ondansetron: prevention of nausea & vomiting in cisplatin based chemotherapy.

Journal of the Medical Association of Thailand = Chotmaihet thangphaet, 1994

Related Questions

What is the treatment for acute nausea?
What are the most effective treatments for refeeding related nausea, comparing anti-emetics (antiemetic medications) such as metoclopramide (Reglan) and ondansetron (Zofran) to cognitive behavioral strategies?
What is the most effective antiemetic (anti-nausea) medication for intravenous (IV) push administration in the Emergency Room (ER) for a patient experiencing severe nausea and vomiting following chemotherapy for pancreatic cancer?
What is the best treatment for emesis (vomiting) and headache?
What is the comparison between 8mg and 4mg of sublingual Zofran (ondansetron)?
What is the approach to evaluating chest pain in a pediatric patient with a history of asthma and a family history of cardiac conditions?
What is the timeframe to observe results of spironolactone (an antiandrogen medication) on androgen levels in an adult female patient with excess androgen activity, such as hirsutism, acne, or polycystic ovary syndrome (PCOS)?
What is the recommended dosage of apixaban for adults with atrial fibrillation, deep vein thrombosis, or pulmonary embolism, considering factors such as kidney disease, age, and weight?
What is the evidence for using olive oil and apple cider vinegar for heart health in patients with or at risk for cardiovascular disease?
What is the best approach to manage osteoarthritis in a patient with anterolateral left hip pain, scoliosis, hypercholesterolemia, and currently taking tramadol (tramadol hydrochloride)?
How is the nitrofurantoin (antibiotic) breakpoint calculated for a patient with a urinary tract infection (UTI)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.